855 results match your criteria Congestive Heart Failure[Journal]


Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction.

Congest Heart Fail 2013 Jul-Aug;19(4):E35-9

Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Diastolic dysfunction of the heart is correlated with cardiac mortality. Serum cystatin C (CysC) is an endogenous marker of kidney function. It is not clear whether serum CysC is associated with diastolic dysfunction in patients with varying cardiac conditions with concomitant diastolic abnormalities and preserved ejection fraction (EF). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12039DOI Listing
February 2014
8 Reads

Thiamine supplementation for the treatment of heart failure: a review of the literature.

Congest Heart Fail 2013 Jul-Aug;19(4):214-22

Wegmans Pharmacy, Ithaca, NY 14850, USA.

A systematic review of the literature was performed by searching Pubmed and EMBASE databases using the terms "thiamine," "vitamin B1," "heart failure," "systolic dysfunction," "ventricular dysfunction," "cardiomyopathy," "ventricular failure," and "systolic failure." Relevant trials and articles were evaluated pertaining to thiamine deficiency in patients with heart failure (HF) and references were searched for further inclusion of articles. A total of 20 articles were reviewed and summarized in detail. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/chf.12037
Publisher Site
http://dx.doi.org/10.1111/chf.12037DOI Listing
February 2014
38 Reads

Preload reserve is restored in patients with decompensated chronic heart failure who respond to treatment.

Congest Heart Fail 2013 Jul-Aug;19(4):207-13

CERIC, Clinique Ambroise Paré, Neuilly-sur-Seine, France.

The authors designed this prospective study to show the relationship between preload reserve and treatment effectiveness of chronic heart failure (CHF). Fifty patients, aged 77±24 years, with decompensated CHF (B-type brain natriuretic peptide [BNP] >1000 pg/mL) were included. Preload reserve was assessed by the changes in contraction indices during a passive leg raise (PLR). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12033DOI Listing
February 2014
8 Reads

Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure.

Congest Heart Fail 2013 Jul-Aug;19(4):200-6

Division of Cardiology, St Joseph Mercy Oakland Hospital, Pontiac, MI 48341, USA.

Providing effective discharge instructions, appropriate dose uptitration, education regarding heart failure (HF) monitoring, and strict follow-up have all been shown to decrease readmissions for HF but are all underutilized. The authors developed and evaluated the impact of a quality-improvement HF checklist as a tool to remind physicians to improve quality of care in HF patients. The checklist was used in randomly selected patients admitted with a primary diagnosis of acute decompensated HF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12031DOI Listing
February 2014
65 Reads

Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure.

Congest Heart Fail 2013 Jul-Aug;19(4):165-71

Division of Cardiovascular Medicine, University of Louisville, Louisville, KY 40241, USA.

Persistent atrial flutter (AFL) in left ventricular assist device (LVAD) recipients can result in loss of AV synchrony, impaired ventricular filling and right heart failure (RHF). The authors report the largest series of HeartMate II (HMII) patients who developed AFL with decompensated RHF, which successfully resolved with AFL ablation. Eight patients with HMII LVAD (mean age, 57±12 years) had medically refractory AFL, with 7 developing de novo AFL after LVAD implant (onset range, 2 days-22 months post-implant). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12034DOI Listing
February 2014
31 Reads

Prognosis of morbid obesity patients with advanced heart failure.

Congest Heart Fail 2013 Jul-Aug;19(4):160-4

Department of Hospital Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Obese patients have been noted to have better prognosis in many conditions including heart failure. We hypothesize that this favorable prognosis for obesity may not be seen in patients with morbid obesity and advanced heart failure. A total of 501 consecutive patients with advanced heart failure referred for heart transplant evaluation to the Cleveland Clinic were studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12038DOI Listing
February 2014
6 Reads

CHF reader notification of cessation.

Authors:

Congest Heart Fail 2013 Jul-Aug;19(4):157

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12041DOI Listing
February 2014
7 Reads

Uremic cardiomyopathy: an underdiagnosed disease.

Congest Heart Fail 2013 Jul-Aug;19(4):E40-5. Epub 2013 Apr 25.

Department of Cardiology, UMDNJ, New Jersey Medical School, Newark, NJ 07103, USA.

Uremic cardiomyopathy is responsible for high morbidity and mortality rates among patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD); however, the early implementation of hemodialysis may halt its progression. Nonconventional hemodialysis, such as frequent hemodialysis, appears to have an advantage over conventional hemodialysis. Kidney transplantation has been shown to reverse uremic cardiomyopathy and to confer a significant survival advantage over hemodialysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12030DOI Listing
February 2014
19 Reads

Predictors of left ventricular function deterioration in patients with left bundle branch block and ejection fraction >50%.

Congest Heart Fail 2013 Jul-Aug;19(4):E1-4. Epub 2013 Apr 15.

Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Resynchronization therapy has become standard of care in patients with left bundle branch block (LBBB), congestive heart failure (CHF), and low ejection fraction (EF). In order to characterize the left ventricular (LV) function evolution in patients with LBBB and baseline preserved LVEF, records of all patients who visited an academic echocardiography laboratory during a period of 4 years were retrospectively investigated. Patients were included if they had a baseline EF >50%, LBBB on surface electrocardiography, and at least one follow-up echocardiogram no earlier than 3 months after the baseline study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12028DOI Listing
February 2014
9 Reads

Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.

Congest Heart Fail 2013 Jul-Aug;19(4):172-9. Epub 2013 Mar 20.

Columbia University Medical Center, New York, NY, USA.

Anemia, a common comorbidity in older adults with heart failure and a preserved ejection fraction (HFPEF), is associated with worse outcomes. The authors quantified the effect of anemia treatment on left ventricular (LV) structure and function as measured by cardiac magnetic resonance (CMR) imaging. A prospective, randomized single-blind clinical trial (NCT NCT00286182) comparing the safety and efficacy of epoetin alfa vs placebo for 24 weeks in which a subgroup (n=22) had cardiac magnetic resonance imaging (MRI) at baseline and after 3 and 6 months to evaluate changes in cardiac structure and function. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816505PMC
February 2014
10 Reads

Can vitamin D supplementation improve the severity of congestive heart failure?

Congest Heart Fail 2013 Jul-Aug;19(4):E22-8. Epub 2013 Mar 21.

Department of Heart Failure and Transplantation, Fellowship in Heart Failure & Transplantation, Rajaei Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran.

The aim of the present study was to investigate whether vitamin D supplementation could improve biochemical findings and functional capacity of patients with heart failure (HF). One hundred patients with New York Heart Association (NYHA) class I through III HF were included in this prospective study and their 25-hydroxyvitamin D levels were evaluated. Only 6% of the participants had a sufficient serum concentration of 25(OH) D >30 nmol/L. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12026DOI Listing
February 2014
5 Reads

Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure.

Congest Heart Fail 2013 Jul-Aug;19(4):E29-34. Epub 2013 Mar 20.

Department of Psychology, Kent State University, Kent, OH 44242, USA.

Cognitive impairment is common in heart failure (HF) and believed to be the result of cerebral hypoperfusion and subsequent brain changes including white matter hyperintensities (WMHs). The current study examined the association between cerebral blood flow and WMHs in patients with HF and the relationship between WMHs and cognitive impairment. Sixty-nine patients with HF completed the Mini-Mental State Examination (MMSE) and underwent echocardiography, transcranial Doppler sonography for cerebral blood flow velocity of the middle cerebral artery, and brain magnetic resonance imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692594PMC
February 2014
7 Reads

Association between weight loss and improvement of ventricular systolic function in advanced heart failure.

Congest Heart Fail 2013 Jul-Aug;19(4):186-91. Epub 2013 Feb 14.

Department of Cardiology, University of South Florida, Tampa, FL 33606, USA.

In heart failure (HF), longitudinal changes in ventricular ejection fraction are poorly studied. The authors' objective was to document the dynamic changes in systolic function of both ventricles during acute HF and after a 3-month follow-up period, and to identify factors associated with ventricular improvement. A limited access dataset from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial provided by The National Heart, Lung, and Blood Institute was analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12024DOI Listing
February 2014
12 Reads

Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium.

Congest Heart Fail 2013 Jul-Aug;19(4):E5-8. Epub 2013 Jan 25.

San Antonio Cardiovascular Proteomics Center, The University of Texas Health Science Center, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640770PMC
February 2014
6 Reads

A novel approach to monitoring pulmonary congestion in heart failure: initial animal and clinical experiences using remote dielectric sensing technology.

Congest Heart Fail 2013 May-Jun;19(3):149-55. Epub 2013 Jan 25.

Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Despite current therapies and disease management approaches, rates of heart failure (HF) rehospitalization remain high. New tools are needed to assess preclinical (asymptomatic) pulmonary congestion to enable outpatient management. Hence, a novel monitoring system based on noninvasive remote dielectric sensing (ReDS) technology was developed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12021DOI Listing
January 2014
7 Reads

A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.

Congest Heart Fail 2013 Mar-Apr;19(2):53-60. Epub 2013 Jan 21.

Division of Hospital Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Despite the widespread use of loop diuretics to treat acute decompensated heart failure (ADHF), robust data supporting their role and optimal dosing strategies are scarce. This analysis aimed to compare clinical outcomes of patients admitted with ADHF who received a diuretic dosing protocol with those who received the usual diuretic therapy. We performed an observational medical records review to compare the use of a nurse-driven diuretic dosing protocol with usual diuretic dosing for patients admitted with ADHF during a 1-year period. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/chf.12020
Publisher Site
http://dx.doi.org/10.1111/chf.12020DOI Listing
December 2013
12 Reads

Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C.

Congest Heart Fail 2013 Jul-Aug;19(4):E17-21. Epub 2013 Jan 7.

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Worsening renal function (WRF) during treatment of acute decompensated heart failure (ADHF) is generally associated with adverse outcomes. An increase ≥0.3 mg/dL in creatinine level is widely used as the definition of WRF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622818PMC
February 2014
5 Reads

Biomarkers in acute heart failure: from risk markers to therapeutic targets.

Congest Heart Fail 2013 Mar-Apr;19(2):51-2. Epub 2012 Dec 28.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12019DOI Listing
December 2013
7 Reads

What is causing extremely elevated amino terminal brain natriuretic peptide in cancer patients?

Congest Heart Fail 2013 May-Jun;19(3):143-8. Epub 2012 Dec 28.

Department of Internal Medicine, University of South Florida and Moffitt Cancer Center, Tampa, FL, USA.

High levels of B-type natriuretic peptide in cancer patients are poorly studied. Previously published data suggest that they are not related to fluid overload and are encountered mostly in solid cancers. The authors investigated the distribution of amino terminal pro-brain natriuretic peptide (NT-proBNP) between hematologic and solid organ malignancies and the relationship of NT-proBNP with volume status in oncologic patients. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/chf.12018
Publisher Site
http://dx.doi.org/10.1111/chf.12018DOI Listing
January 2014
12 Reads

Remote care costs for congestive heart failure: a systematic review and meta-analysis of randomized controlled trials in the United States comparing remote versus more intensive care settings.

Congest Heart Fail 2013 Jul-Aug;19(4):192-9. Epub 2012 Dec 28.

Medical Device Consultants of Ridgewood, LLC, Ridgewood, NJ, USA.

It has been assumed that less intense levels of care for managing heart failure result in a lowering of the overall costs for this care in the United States. The objective of this review was to determine whether this assumption is correct. A systematic review was performed using Medline, technology assessment Web sites, and relevant cardiovascular and heart failure journals from the year 2000 to the present. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12017DOI Listing
February 2014
6 Reads

Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.

Congest Heart Fail 2013 May-Jun;19(3):135-42. Epub 2012 Dec 28.

Cardiology Division, Massachusetts General Hospital, Boston, MA 02114, USA.

Many proven heart failure (HF) therapies decrease N-terminal pro B-type natriuretic peptide (NT-proBNP) values over time, yet some patients have an NT-proBNP >1000 pg/mL following treatment, which is associated with poor outcomes. A total of 151 patients with left ventricular systolic dysfunction were treated with aggressive HF therapy in the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study. Clinical characteristics and NT-proBNP were measured at each visit during 10 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12016DOI Listing
January 2014
25 Reads

Self-management intervention to improve self-care and quality of life in heart failure patients.

Congest Heart Fail 2013 Jul-Aug;19(4):E9-E16. Epub 2012 Dec 28.

National Taipei University of Nursing and Health Science, Taipei, Taiwan.

Self-management intervention is a good method to improve self-care ability, as such, to promote quality of life. However, the research focused on self-management intervention in heart failure patients in Taiwan is very limited. Therefore, the purposes of this study were to test the effectiveness of self-management intervention in patients with heart failure in Taiwan and examine the relationship between self-care ability and quality of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12014DOI Listing
February 2014
10 Reads

Prognostic implications of relative hypochromia in ambulatory patients with chronic systolic heart failure.

Congest Heart Fail 2013 Jul-Aug;19(4):180-5. Epub 2012 Dec 19.

Department of Medicine, Fairview Health Services, Minneapolis, MN, USA.

Iron insufficiency has been associated with heart failure, but the impact of a reduction of hemoglobin content in the erythrocytes as estimated by mean corpuscular hemoglobin concentration (MCHC) to myocardial structure, performance, and long-term clinical outcomes has not been well-established. The authors examined hematologic data and long-term outcomes of 197 ambulatory patients with chronic systolic and symptomatic heart failure who underwent comprehensive echocardiographic evaluation. The authors observed that relative hypochromia (defined as low MCHC) was associated with higher natriuretic peptide levels (NT-proBNP, r =-0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620796PMC
February 2014
12 Reads

Left ventricular ejection fraction and left ventricular end-diastolic volume in patients with diastolic dysfunction.

Congest Heart Fail 2013 May-Jun;19(3):130-4. Epub 2012 Dec 12.

Department of Medicine/Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 23249, USA.

Diastolic dysfunction can be diagnosed on equilibrium radionuclide angiocardiography (ERNA) by a low peak filling rate (PFR) in the setting of a normal left ventricular ejection fraction (LVEF). The authors evaluated the relationship between diastolic dysfunction, LVEF, and end-diastolic volume (EDV). A total of 408 predominantly asymptomatic patients with an LVEF ≥50% by ERNA were studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12013DOI Listing
January 2014
6 Reads

Potentials of cystatin C and uric acid for predicting prognosis of heart failure.

Congest Heart Fail 2013 May-Jun;19(3):123-9. Epub 2012 Dec 12.

Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.

Few studies have explored the clinical potentials of combined Cystatin C (Cys) and uric acid (UA) in heart failure (HF). The authors evaluated Cys and UA as predictors of clinical outcomes compared with conventional renal biomarkers. This prospective cohort study included 587 HF patients presenting with dyspnea. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/chf.12012
Publisher Site
http://dx.doi.org/10.1111/chf.12012DOI Listing
January 2014
5 Reads

When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist?

Congest Heart Fail 2013 May-Jun;19(3):107-15. Epub 2012 Dec 12.

New York University School of Medicine, New York, NY 10016, USA.

In patients on conventional heart failure therapy including angiotensin-converting enzyme (ACE) inhibitors, the addition of angiotensin receptor blockers (ARBs), direct renin inhibitors (DRIs), or aldosterone antagonists are therapeutic options to further reduce the risk of cardiovascular events. However, whether one is preferable over the other is not known. PubMed, EMBASE, and Cochrane Central Register of Controlled Trials databases were searched for randomized clinical trials (RCTs), until March 2011, of trials testing either an ARB, DRI, or an aldosterone antagonist in patients with heart failure who were on conventional heart failure therapy with follow-up of at least 3 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12011DOI Listing
January 2014
7 Reads

Is chronic sildenafil therapy safe and clinically beneficial in patients with systolic heart failure?

Congest Heart Fail 2013 Mar-Apr;19(2):99-103. Epub 2012 Dec 12.

Department of Heart Failure and Transplantation, Rajaei Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Sildenafil is a selective phosphodiesterase-5 inhibitor and causes vasodilatation, particularly in pulmonary circulation. Since left heart failure may be associated with pulmonary hypertension "out of proportion to left heart disease," sildenafil may have beneficial effect in such patients. The present investigation was designed as a 12-week, single-center, randomized, double-blind, placebo-controlled study evaluating the effects of sildenafil on mean blood pressure (primary endpoint) in patients with left systolic heart failure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12008DOI Listing
December 2013
6 Reads

Exaggerated NT-proBNP production in patients with hematologic malignancies: a case series.

Congest Heart Fail 2012 Nov-Dec;18(6):333-6. Epub 2011 Oct 17.

Department of Internal Medicine, University of South Florida and Moffitt Cancer Center, Tampa, FL, USA.

©2011 Wiley Periodicals Inc. Extremely elevated serum brain natriuretic peptide (BNP) in cancer patients is a poorly understood phenomenon. The authors report three cases of patients with hematologic malignancies and serial N-terminal pro-BNP (NT-proBNP) measurements with values in the range of tens to hundred thousands pg/mL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2011.00258.xDOI Listing
November 2013
7 Reads

Utility of right ventricular strain imaging in predicting pulmonary vascular resistance in patients with pulmonary hypertension.

Congest Heart Fail 2013 May-Jun;19(3):116-22. Epub 2012 Nov 5.

Shaheed Rajaei Cardiovascular, Medical and Research Center, Heart Failure and Transplantation Department, Tehran University of Medical Sciences, Tehran, Iran.

Pulmonary vascular resistance (PVR) has important prognostic implications in the assessment of patients with pulmonary hypertension. Using echocardiography to measure PVR would have the advantage of being able to follow patients serially and to assess their response to treatment noninvasively. The authors sought to assess whether right ventricular strain rate imaging (SRI) can predict PVR in patients with pulmonary hypertension. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12009DOI Listing
January 2014
10 Reads

Low-density lipoprotein levels in patients with acute heart failure.

Congest Heart Fail 2013 Mar-Apr;19(2):85-91. Epub 2012 Oct 16.

Department of Internal Medicine, Mount Sinai Medical Center, New York, NY, USA.

Statins do not appear to have a significant benefit in heart failure (HF) as they do in coronary artery disease (CAD). Significant evidence exists that low serum cholesterol levels may be harmful in HF. This study sought to determine the optimal low-density lipoprotein (LDL) level in patients hospitalized with acute HF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12006DOI Listing
December 2013
8 Reads

Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure.

Congest Heart Fail 2013 Mar-Apr;19(2):92-8. Epub 2012 Oct 12.

College of Nursing, University of South Florida, Tampa, FL, USA.

There is abundant evidence on inflammatory mechanisms in heart failure (HF) that are used for prognostication of the disease; however, data are lacking regarding the association between elevated cytokines, C-reactive protein (CRP), and cognition in HF. A cross-sectional pilot study of 38 patients with HF, aged 62 years (standard deviation± 9 years), predominantly men (68%) and Caucasian (79%) were screened for cognitive function using the Montreal Cognitive Assessment (MoCA). The study aimed to examine cognitive scores on MoCA with cytokines, interleukin 6 [IL-6] and tumor necrosis factor α [TNF-α], and CRP as indicators of early cognitive changes in HF. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/chf.12007
Publisher Site
http://dx.doi.org/10.1111/chf.12007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801169PMC
December 2013
8 Reads

Tai chi in patients with heart failure with preserved ejection fraction.

Congest Heart Fail 2013 Mar-Apr;19(2):77-84. Epub 2012 Oct 12.

Osher Center for Integrative Medicine, Harvard Medical School, Boston, MA, USA.

Although exercise is an important component of heart failure management, optimal regimens, particularly in heart failure with preserved ejection fraction (HFPEF), are uncertain. Tai chi (TC) is a mind-body exercise that may have potential benefits but has not been studied in this population. The authors randomized 16 patients with HFPEF to either 12 weeks TC or aerobic exercise. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546234PMC
December 2013
7 Reads

The role of natriuretic peptides: from the emergency department throughout hospitalization.

Congest Heart Fail 2012 Sep-Oct;18 Suppl 1:S5-8

Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Assessment of natriuretic peptide (NP) levels has a well-established role in the diagnosis and prognosis of acute heart failure (AHF) patients. Current guidelines recommend assessment of NPs when the diagnosis is in question, yet multiple studies suggest a broader value of NP assessment. Measurement of NP levels results in more efficient treatment, resource utilization (ie, reduced costs), and possibly improved short- and long-term outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00307.xDOI Listing
January 2013
6 Reads

Clinical outcomes after tricuspid valve annuloplasty in addition to mitral valve surgery.

Congest Heart Fail 2013 Mar-Apr;19(2):70-6. Epub 2012 Oct 1.

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Current guidelines recommend tricuspid valve annuloplasty (TVP) together with mitral valve surgery in cases of tricuspid annulus dilation (≥40 mm) or functional tricuspid valve regurgitation >2/4. Baseline clinical and echocardiographic data of patients undergoing mitral valve surgery in a single tertiary care hospital between 2007 and 2010 were analyzed. Mortality and heart failure hospitalization data were collected and groups with or without TVP were compared. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12004DOI Listing
December 2013
11 Reads

Predictors of right ventricular systolic dysfunction in compensated and decompensated heart failure.

Congest Heart Fail 2012 Sep-Oct;18(5):278-83. Epub 2012 Apr 4.

Department of Cardiology, University of South Florida, Tampa, FL 33606, USA.

Current understanding of the mechanisms of right ventricular (RV) systolic dysfunction in heart failure (HF) is limited. The authors analyzed a limited access dataset from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) provided by the National Heart, Lung, and Blood Institute (NHLBI). RV systolic function was measured by echocardiography at baseline and at 3-month follow-up using fractional area change. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00289.xDOI Listing
March 2013
11 Reads

Ultrasound pleural effusion sign as a useful marker for identifying heart failure worsening in established heart failure patients during follow-up.

Authors:
Hajime Kataoka

Congest Heart Fail 2012 Sep-Oct;18(5):272-7. Epub 2012 Mar 13.

Division of Internal Medicine, Nishida Hospital, Oita, Japan.

Clinical significance of UltraSound Pleural Effusion (US-PLE) and test characteristics of this sign for identifying worsening heart failure (HF) during follow-up of HF patients are unclear. Clinical records of 83 established HF patients were examined. The diagnosis of worsening HF was classified as "highly certain,"probable,"uncertain," or "no" based on the combination of the changes in symptoms/signs and B-type natriuretic peptide (BNP). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00285.xDOI Listing
March 2013
8 Reads

A comparison of criterion standard methods to diagnose acute heart failure.

Congest Heart Fail 2012 Sep-Oct;18(5):262-71. Epub 2012 Apr 4.

Department of Emergency Medicine, Vanderbilt University, Nashville, TN 37232, USA.

The authors sought to compare and contrast the clinical criterion standards currently used in a cohort of emergency department (ED) patients to diagnose acute heart failure syndromes (AHFS). In a prospective observational study of patients with signs and symptoms of AHFS, 3 criterion standards were examined: (1) the treating ED physician's diagnosis; (2) the hospital discharge diagnosis; and (3) a diagnosis based on medical record review by a panel of cardiologists. Using Cohen's kappa (κ) coefficient, the authors assessed agreement and then compared the different standards by repeatedly setting one as the criterion standard and the other two as index tests. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00288.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458712PMC
March 2013
14 Reads

Risk score model for predicting mortality in advanced heart failure patients followed in a heart failure clinic.

Congest Heart Fail 2012 Sep-Oct;18(5):254-61. Epub 2012 Mar 13.

Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

The prevalence of heart failure (HF) in the population is increasing, concomitant with high incidence of rehospitalizations and mortality. The aim of this study was to characterize a prognostic risk score model for patients with chronic HF. A total of 500 patients followed at the HF clinic were evaluated by clinical, functional, laboratory, imaging, and therapeutic variables that were correlated to mortality during a follow-up period of 25 months. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1751-7133.2012.00286.x
Publisher Site
http://dx.doi.org/10.1111/j.1751-7133.2012.00286.xDOI Listing
March 2013
9 Reads

Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.

Congest Heart Fail 2012 Sep-Oct;18(5):239-44. Epub 2012 Mar 13.

Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

Neutrophil gelatinase-associated lipocalin (NGAL) is upregulated systemically and by renal tubular cells in response to inflammation and ischemia. Recent interests in NGAL have focused on its ability to predict worsening renal function. However, as an iron-regulatory glycoprotein, the relationship between systemic NGAL levels and indices of anemia has not been examined. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1751-7133.2012.00287.x
Publisher Site
http://dx.doi.org/10.1111/j.1751-7133.2012.00287.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458715PMC
March 2013
7 Reads

Relationship of cardiac magnetic resonance imaging and myocardial biopsy in the evaluation of nonischemic cardiomyopathy.

Congest Heart Fail 2013 Jan-Feb;19(1):29-38. Epub 2012 Sep 11.

Division of Cardiovascular Medicine, Davis Heart Lung Research Institute, The Ohio State University Medical Center, Columbus, OH 43210, USA.

This study was performed to determine the relative role of cardiac magnetic resonance (CMR) imaging and endomyocardial biopsy (EMB) in the evaluation of cardiomyopathy. Sixty-six patients with a clinical diagnosis of nonischemic dilated cardiomyopathy or restrictive cardiomyopathy underwent both EMB and CMR imaging as part of their diagnostic evaluation. The authors retrospectively reviewed the results of these two methods to determine their diagnostic impact and congruency. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12003DOI Listing
December 2013
5 Reads

Rate of change in physical fitness and quality of life and depression following exercise training in patients with congestive heart failure.

Congest Heart Fail 2013 Jan-Feb;19(1):1-5. Epub 2012 Sep 11.

School of Science and Technology, University of New England, Armidale, NSW, Australia.

Exercise training appears to improve peak oxygen consumption (VO(2) ) and quality of life (QOL) in heart failure patients, although disease etiology, patient demographics and medication may alter the rate of adaptation. The authors sought to identify rate of change from baseline in fitness, QOL, and depression following exercise training in a cohort of patients with congestive heart failure. Thirty male systolic heart failure patients (aged 63. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12002DOI Listing
December 2013
8 Reads

Heart rate control in patients with chronic atrial fibrillation and heart failure.

Congest Heart Fail 2013 Jan-Feb;19(1):25-8. Epub 2012 Sep 9.

VA Loma Linda Healthcare System, Section of Cardiology, Loma Linda, CA 92357, USA.

The goal of this study was to determine whether aggressive heart rate (HR) control in patients with both chronic atrial fibrillation (AF) and heart failure (HF) is associated with improved outcomes. HR control is one of the mainstays in management of patients with AF. However, rate control can be challenging in patients with HF. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1751-7133.2012.00309.x
Publisher Site
http://dx.doi.org/10.1111/j.1751-7133.2012.00309.xDOI Listing
December 2013
7 Reads

Patient-reported selective adherence to heart failure self-care recommendations: a prospective cohort study: the Atlanta Cardiomyopathy Consortium.

Congest Heart Fail 2013 Jan-Feb;19(1):16-24. Epub 2012 Sep 9.

Division of Cardiology, Emory University, Atlanta, GA 30322, USA.

Simultaneous adherence with multiple self-care instructions among heart failure (HF) patients is not well described. Patient-reported adherence to 8 recommendations related to exercise, alcohol, medications, smoking, diet, weight, and symptoms was assessed among 308 HF patients using the Medical Outcomes Study Specific Adherence Scale questionnaire (0="never" to 5="always," maximum score=40). A baseline cumulative score of ≥32/40 (average ≥80%) defined good adherence. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00308.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519965PMC
December 2013
28 Reads

Cognitive profile in persons with systolic and diastolic heart failure.

Congest Heart Fail 2013 Jan-Feb;19(1):44-50. Epub 2012 Sep 9.

College of Nursing, University of South Florida, Tampa, FL 33612, USA.

Persons with heart failure (HF) have four times the risk of having cognitive impairment compared with the general population and display different patterns of cognitive impairment. This secondary analysis of a published cross-sectional study of 90 community-dwelling adults examined the Montreal Cognitive Assessment (MoCA) scores and HF differentiated as systolic and diastolic HF. Mean MoCA score was 22. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12001DOI Listing
December 2013
7 Reads

Is exercise training beneficial for heart failure patients taking β-adrenergic blockers? A systematic review and meta-analysis.

Congest Heart Fail 2013 Mar-Apr;19(2):61-9. Epub 2012 Sep 9.

School of Science and Technology, University of New England, Armidale, NSW, Australia.

The authors sought to conduct a systematic review comparing the effects of exercise training in heart failure patients taking β-blockers vs those not. A systematic search of exercise training trials in chronic heart failure patients that compared groups who took β-blocker medication or compared selective and nonselective β-blockers during exercise training was conducted. Eight prospective studies met the criteria for the quantitative synthesis, which included data from 236 participants. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/chf.12000DOI Listing
December 2013
9 Reads

Natriuretic peptide testing for predicting adverse events following heart failure hospitalization.

Congest Heart Fail 2012 Sep-Oct;18 Suppl 1:S9-S13

Cardiology Division, Massachusetts General Hospital, 32 Fruit St., Boston, MA 02114, USA.

Concentrations of both B-type natriuretic peptide (BNP) and amino-terminal pro-BNP (NT-proBNP) are useful for diagnostic evaluation of patients with acute decompensated heart failure (ADHF), providing important information regarding presence and severity of heart failure. In addition, levels of both BNP and NT-proBNP are strongly prognostic for adverse outcomes in this setting. While values for BNP and NT-proBNP at hospital admission predict impending risk for adverse outcome, their measurement following HF treatment provides incremental prognostic information, even more accurately identifying patients at highest risk for death or rehospitalization in the short term. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00306.xDOI Listing
January 2013
4 Reads

Post-acute care: the role of natriuretic peptides.

Congest Heart Fail 2012 Sep-Oct;18 Suppl 1:S14-6

San Diego VA Medical Hospital and University of California-San Diego, CA 92161, USA.

Heart failure is a chronic disease marked by variable acute exacerbations. Once hospitalized the decompensated patient may have signs and symptoms only partially reversed, medical therapy only partially optimized and deranged physiology only partially restored. Therefore, the post-acute care period is one of unique vulnerability and merits efforts of careful and comprehensive assessment of patients at risk of recurrent decompensation and rehospitalization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00304.xDOI Listing
January 2013
7 Reads

Scope of heart failure hospitalization.

Congest Heart Fail 2012 Sep-Oct;18 Suppl 1:S1-4

Cardiology Division, Emory University School of Medicine, Atlanta, GA 30322, USA.

The growing heart failure (HF) epidemic places an enormous clinical and economic burden on the health care system. The clinical and financial burden related to HF hospitalizations has led to great interest in both improving related outcomes and decreasing costs of care. Besides adhering to existing guidelines, newer approaches to managing these patients, both in terms of monitoring and developing novel therapeutic approaches, are needed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1751-7133.2012.00305.xDOI Listing
January 2013
5 Reads